Bruce N. Jacobs, Chief Financial Officer at Kymera Therapeutics, Inc. (KYMR), sold 20,000 shares at $60.17 ($1.2M) on 2021-03-15, disclosed to the SEC on 2021-03-15.
Open-market sale of $1.2M KYMR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.07 | 1,805 | $108K | 9.0% |
| 2 | $60.07 | 1,805 | $108K | 9.0% |
| 3 | $60.17 | 8,195 | $493K | 41.0% |
| 4 | $60.17 | 8,195 | $493K | 41.0% |
| Total | $60.15 avg | 20,000 | $1.2M | 100% |
| Filing → |
| KYMR | SELL | 2025-09-17 | $4.0M | — | Filing → |
| KYMR | SELL | 2025-03-03 | $389K | — | Filing → |
| KYMR | SELL | 2024-03-04 | $318K | — | Filing → |